Terrance P. Coyne, a director at Royalty Pharma plc (RPRX), divested 32,916 shares of the company's stock on February 25, 2026. The transaction, executed at an average price of $45.32 per share, amounted to approximately $1.49 million.
This sale represents a notable transaction by a company insider. While insider sales can be motivated by various personal financial reasons such as diversification or tax planning, they are closely monitored by market participants for any potential signaling effect.
Royalty Pharma plc operates in the biopharmaceutical industry, providing capital to leading pharmaceutical companies. Recent insider activity also includes sales by Marshall Urist, another director, earlier this year.